Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

TELMISARTAN-DRLA TABLETS 80MG

Approval Number

SIN17074P

Drug Name

TELMISARTAN-DRLA TABLETS 80MG

Product Name

TELMISARTAN-DRLA TABLETS 80MG

Approval Date

August 30, 2024

Registrant

ZYFAS PHARMA PTE LTD

Regulatory Information

Registrant

ZYFAS PHARMA PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET

Route of Administration

ORAL

Medical Information

ATC Code

C09CA07

Manufacturer Information

Pharmaceutical Manufacturer

ZYFAS PHARMA PTE. LTD.

Manufacturers

DR. REDDY'S LABORATORIES LTD. - FTO 2

Active Ingredients

Ingredient Name

TELMISARTAN

Strength

80.000mg

Drug MonographTelmisartan

Documents

Package Inserts

TELMISARTAN-DRLA TABLET PI.pdf

Approved: August 30, 2024

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy